BACKGROUND: Marijuana intoxication appears to impair response inhibition, but it is unclear if impaired inhibition and associated brain abnormalities persist after prolonged abstinence among adolescent users. We hypothesized that brain activation during a go/no-go task would show persistent abnormalities in adolescent marijuana users after 28 days of abstinence. METHODS: Adolescents with (n = 16) and without (n = 17) histories of marijuana use were compared on blood oxygen level dependent (BOLD) response to a go/no-go task during functional magnetic resonance imaging (fMRI) after 28 days of monitored abstinence. Participants had no neurological problems or Axis I diagnoses other than cannabis abuse/dependence. RESULTS: Marijuana users did not differ from non-users on task performance but showed more BOLD response than non-users during inhibition trials in right dorsolateral prefrontal, bilateral medial frontal, bilateral inferior and superior parietal lobules, and right occipital gyri, as well as during "go" trials in right prefrontal, insular, and parietal cortices (p < 0.05, clusters > 943 microl). Differences remained significant even after controlling for lifetime and recent alcohol use. CONCLUSIONS: Adolescent marijuana users relative to non-users showed increased brain processing effort during an inhibition task in the presence of similar task performance, even after 28 days of abstinence. Thus, increased brain processing effort to achieve inhibition may predate the onset of regular use or result from it. Future investigations will need to determine whether increased brain processing effort is associated with risk to use.
BACKGROUND: Marijuana intoxication appears to impair response inhibition, but it is unclear if impaired inhibition and associated brain abnormalities persist after prolonged abstinence among adolescent users. We hypothesized that brain activation during a go/no-go task would show persistent abnormalities in adolescent marijuana users after 28 days of abstinence. METHODS: Adolescents with (n = 16) and without (n = 17) histories of marijuana use were compared on blood oxygen level dependent (BOLD) response to a go/no-go task during functional magnetic resonance imaging (fMRI) after 28 days of monitored abstinence. Participants had no neurological problems or Axis I diagnoses other than cannabis abuse/dependence. RESULTS: Marijuana users did not differ from non-users on task performance but showed more BOLD response than non-users during inhibition trials in right dorsolateral prefrontal, bilateral medial frontal, bilateral inferior and superior parietal lobules, and right occipital gyri, as well as during "go" trials in right prefrontal, insular, and parietal cortices (p < 0.05, clusters > 943 microl). Differences remained significant even after controlling for lifetime and recent alcohol use. CONCLUSIONS: Adolescent marijuana users relative to non-users showed increased brain processing effort during an inhibition task in the presence of similar task performance, even after 28 days of abstinence. Thus, increased brain processing effort to achieve inhibition may predate the onset of regular use or result from it. Future investigations will need to determine whether increased brain processing effort is associated with risk to use.
Authors: B Luna; K R Thulborn; D P Munoz; E P Merriam; K E Garver; N J Minshew; M S Keshavan; C R Genovese; W F Eddy; J A Sweeney Journal: Neuroimage Date: 2001-05 Impact factor: 6.556
Authors: Alecia D Schweinsburg; Martin P Paulus; Valerie C Barlett; Lauren A Killeen; Lisa C Caldwell; Carmen Pulido; Sandra A Brown; Susan F Tapert Journal: Ann N Y Acad Sci Date: 2004-06 Impact factor: 5.691
Authors: Andrew C H Chen; Bernice Porjesz; Madhavi Rangaswamy; Chella Kamarajan; Yongqiang Tang; Kevin A Jones; David B Chorlian; Arthur T Stimus; Henri Begleiter Journal: Alcohol Clin Exp Res Date: 2007-01 Impact factor: 3.455
Authors: Kurt P Schulz; Jin Fan; Cheuk Y Tang; Jeffrey H Newcorn; Monte S Buchsbaum; Angeles M Cheung; Jeffrey M Halperin Journal: Am J Psychiatry Date: 2004-09 Impact factor: 18.112
Authors: P Lafolie; O Beck; G Blennow; L Boréus; S Borg; C E Elwin; L Karlsson; G Odelius; P Hjemdahl Journal: Clin Chem Date: 1991-11 Impact factor: 8.327
Authors: Nadia Solowij; Katy A Jones; Megan E Rozman; Sasha M Davis; Joseph Ciarrochi; Patrick C L Heaven; Nicole Pesa; Dan I Lubman; Murat Yücel Journal: Psychopharmacology (Berl) Date: 2011-09-21 Impact factor: 4.530
Authors: Ian H Harding; Nadia Solowij; Ben J Harrison; Michael Takagi; Valentina Lorenzetti; Dan I Lubman; Marc L Seal; Christos Pantelis; Murat Yücel Journal: Neuropsychopharmacology Date: 2012-04-25 Impact factor: 7.853
Authors: Staci A Gruber; Mary Kathryn Dahlgren; Kelly A Sagar; Atilla Gönenc; William D S Killgore Journal: Neurosci Lett Date: 2012-01-24 Impact factor: 3.046
Authors: Jatin G Vaidya; Robert I Block; Daniel S O'Leary; Laura B Ponto; Mohamed M Ghoneim; Antoine Bechara Journal: Neuropsychopharmacology Date: 2011-09-28 Impact factor: 7.853
Authors: Lindsay M Squeglia; Scott F Sorg; Alecia Dager Schweinsburg; Reagan R Wetherill; Carmen Pulido; Susan F Tapert Journal: Psychopharmacology (Berl) Date: 2011-09-28 Impact factor: 4.530
Authors: Alexander L Wallace; Kristin E Maple; Alicia T Barr; Krista M Lisdahl Journal: Psychopharmacology (Berl) Date: 2020-07-26 Impact factor: 4.530